Our Vision

Our Mission

01

Improve global health through innovative biopharmaceutical solutions from discovery to distribution

02

Translate proven biopharma concepts into life-changing therapies

Turn delivery concepts involving natural or artificial biomaterials to improve the bioavailability of biopharmaceuticals

Advance human health through cutting-edge research, development, and manufacturing

03

04

05

Ensure the safety, efficacy, and accessibility of biopharmaceutical products

06

Foster strategic partnerships, collaborations, and knowledge sharing

07

Provide expert consultancy, advisory services, and regulatory support

Guided by integrity, innovation, and patient-centricity, we strive to make a meaningful impact on global healthcare.

Our Founder Promoters

Our Strength is the background of the founder promoters

SHRUTI VENKITACHALAM

SHRUTI VENKITACHALAM, the founder and Director is a Head and Neck Oncologist (surgeon), passionate about translational medical research. She studied Master’ in Surgery (M. S.) - Otorhinolaryngology at Kasturba Medical College, Manipal (India). She had several opportunities to listen to lectures by the eminent visionary, Prof. Valiathan; who inspired her to approach research with as much zeal as practice medicine. She was honored to receive the award for the best outgoing student in ENT in 2014 from Prof. Valiathan’s hands. Hearing his story about the first heart valves made in India, besides many other products, further nudged her enthusiasm to try and make a mark in translational research from the lab to the patient.

With a passion for specializing in Head and Neck surgery, she worked at Tata Memorial Hospital, Mumbai, for a few months, aided by a competitive grant. Soon after, she did a post-doctoral fellowship for 2 years at Christian Medical College, Vellore. There she received world-class training from some of the best surgeons in India and had the opportunity to serve patients from across the country. Exposure to both these Institutions, besides providing excellent training, allowed her to see from close quarters the socio-economic divide, the need for indigenous drugs and products, and easily accessible and affordable patient care aids in India.

She realized that India is considered the “Oral cancer capital of the world”, accounting for a third of the burden globally. Even with access to the best technology, machinery, and pathologists to investigate, the best surgeons, radiation oncologists, and medical oncologists to treat these patients, exaggerated maintenance/treatment costs due to lack of indigenization are a major social/financial burden to the cancer victims.

She realized that though India made scientific contributions through publications and patents in a vast spectrum of disciplines, a bridge between physicians and basic research scientists is a missing link. Therefore, she seeks to contribute to bridging these socio-economic medical and healthcare divides and fill the gaps by translating research in the laboratories of our country to the field and market to make a difference in the treatment, and therefore lives, of patients, not just in India, but the entire world. So she has worked hard to establish a link with researchers who have proven viable concepts for starting VIVEKBIOPHARMA with a well-defined vision.

Leveraging on four decades of pioneering research expertise in biochemistry, stem cell biology, tissue engineering, and quality control of biomedical products, she also aims to bridge the gap between research and clinical applications. From her early days at Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, she followed the motivational speeches by the visionary founder Prof. MS Valiathan. She is grateful to him for igniting her passion for innovation, and to his successors for encouraging collaboration for leading the cutting-edge research solutions.

From her graduate days in the 1980s to becoming a seasoned research guide, she has dedicated herself to applied research culminating in human resource development through mentoring and nurturing talent, team building and management, fostering collaborative excellence, and research excellence securing many national/international patents and publications in renowned journals.

Now, driven by a renewed sense of purpose, she aims to translate cutting-edge healthcare technologies into tangible impact. By shaping up a cohesive team sharing similar mindsets and commitment, she envisions bridging the gap between innovation and clinical application, developing sustainable, accessible biomedical solutions, and empowering the next generation of researchers and entrepreneurs.

Through forming a company, she seeks to leverage her expertise in biomedical product development, foster strategic collaborations and partnerships, and drive innovation, quality, and regulatory excellence.

LISSY K. KRISHNAN

TARA S is a dedicated biomedical researcher with extensive experience in basic and translational science who is pursuing postdoctoral research at Case Western Reserve University, USA. During her current position, she actively engaged in academia-industry interactions and bridging the gap between academic research and practical applications. Her work spans from studying molecular mechanisms of disease to developing novel drugs and biomimetic matrices for regenerative therapies. Throughout her career, she has consistently focused on projects with strong potential for translational application always driven by the vision of how her discoveries could eventually impact clinical practice and move from bench to bedside.

With a strong background in regenerative medicine from the Biomedical Technology Wing of Sree Chitra Tirunal Institute for Medical Sciences and Technology, Trivandrum, an Institution known for successfully developing and commercializing medical technologies, she gained valuable exposure to the process of bringing innovations from lab to market. Her research culminated in co-inventing an Indian patent on injectable biomimetic fibrin gel composite for spinal cord injury.

Before her doctoral program, she gained one year of industrial experience through the DBT/Biotech Industrial Training Programme. This opportunity provided her with valuable insights into the practical aspects of biomedical research and development in a commercial setting, enhancing her understanding of industry dynamics and requirements, and preparing her for the dynamic environment of a biopharma company.

She has joined VIVEKBIOPHARMA to leverage her passion for translating research into practical therapeutic solutions. Her interests align perfectly with the company's noble mission of improving patient outcomes through cutting-edge biopharmaceutical approaches, more effective treatments, and potentially more affordable healthcare solutions.

TARA S

RENU RAMESH is fascinated by how basic research transforms into translational research. Immediately after her college education while working on a cancer research project at the Regional Cancer Centre, Trivandrum, through a brief international stint at the Kagoshima University Japan sparked her deep fascination with molecular biology. Later by working on a technology development project at the Biomedical Wing at Sree Chitra Tirunal Institute for Medical Sciences and Research, Trivandrum, she was exposed to the complexities of tissue development and regeneration, which subsequently helped her doctoral studies.

Creating a functional tissue model by integrating various biological, chemical, and mechanical factors honed her skills; both in designing experiments and problem-solving. The vibrant ecosystem at SCTIMST allowed her to work alongside engineers, clinicians, and biomaterial scientists bridging the gap between fundamental research and its clinical applications.

While carrying out her postdoctoral research at Kerala University and RCC Trivandrum, with a refined skill she has communicated with various funding agencies effectively to secure financial support for research projects that provided her with valuable administrative experience.

Her background in basic research, combined with her enthusiasm for innovative applications, positions her to make a valuable contribution to the team at VIVEKBIOPHARMA.

RENU RAMESH

In this exciting journey, as the team aims to modify the future of healthcare together, VIVEKBIOPHARMA represents the best vision and goals for unlocking the potential of a few patented biomedical technologies. Building on extensive research expertise, their mission is to bridge the gap between innovation and impact, by delivering breakthrough biopharmaceuticals to improve human health.

Our Advisory Board

Many experts we consulted provided valuable suggestions.

DR. G.S. BHUVANESHWAR, FBSE

Dr. Bhuvaneshwar earned distinguished Alumnus Award from IIT Madras in 1999 and earned his PhD in Biomedical Technology from Sree Chitra Tirunal Institute for Medical Sciences & Technology (SCTIMST) in Trivandrum and holds 14 patents, has authored 6 book chapters, and published >40 research papers. His distinguished 36-year career at SCTIMST made significant contributions to medical device development. His most notable achievement is the development of the TTK-CHITRA HEART VALVE, the CEREDRAIN Hydrocephalus Shunt System and SPICTRA Hollow Fiber Membrane Oxygenator. His contributions have been recognized with several prestigious awards. After retiring from the position of Head of the Biomedical Technology Wing of SCTIMST in 2012, he took the position as Director of Innovation at Trivitron Healthcare Pvt. Ltd. in Chennai for 3 years.

With extensive experience in medical device testing and validation, Dr. Bhuvaneshwar actively mentors startups and faculty in India through various programs, including IITM-HTIC Medical Device Incubator, WRCB of IIT Bombay, and the Centre for Healthcare Entrepreneurship at IIT Hyderabad.

Leveraging on his wide expertise in biomedical technology, currently he holds multiple esteemed positions, including Member of the Technical Advisory Group and Co-Chair of the Scientific Advisory Group (Medical Devices) of the National Biopharma Mission implemented by BIRAC, Govt. of India. He also serves as Adjunct Professor in the Department of Engineering Design at IIT Madras, Visiting Professor in the Healthcare Entrepreneurship Program at IIT Hyderabad, and Advisor to the WRCB at IIT Bombay. Additionally, he consults and advises small and medium medical device companies on technical aspects of device development, regulatory strategy, and QMS documentation.

Dr. Sivarama Krishnan is Associate professor at Indian Institute of Technology - Madras, engaged in physics education and in research on femto- and atto-second dynamics in nanoscale matter.

His Doctoral research is on Experimental Physics earning his Ph.D. from Max Planck Institute for Nuclear Physics, Heidelberg (Germany) - University of Heidelberg, with a top-grade. His post doctoral research was at the Tata Institute of Fundamental research, Hyderabad, after which he worked as Research Engineer at the IBM - SEMICONDUCTOR R&D CENTER

His current research theme is Quantum photonics and dynamics, Meso- and nano-scale physics with fs lasers and advanced photon sources; nonlinear optics; EUV and soft x-ray photophysics earning a US patent to his credit (USPTO 9,301,381);Cyrogenic superfluid He nanodroplets and atomic clusters using fs lasers & synchrotron (EUV) sources; with specific skills on Coincidence and correlation spectroscopy, Time-of-flight & velocity-map-imaging techniques, X-ray spectrometry.

His technical expertise also include: Few-cycle femtosecond (fs) laser system (NIR, Ti:Sapphire)- pulse generation; Superfluid He nanodroplets - Cryogenic (5K) source with inline doping of atoms and molecules;X-ray free-electron laser and synchrotron experiments in the EUV: design and implementation; Nonlinear optics: optical harmonic generation, four-wave mixing, optical phase conjugation; Time-of- flight and velocity-map-imaging spectrometry.

Honors and awards are Early Career Research Award of DST (Govt. Of India) and Nominated Head of Max Planck Partner Group (Max Planck Society, Germany ) .

He has 65+ publications with 1000 citation and an h-index of 17. He has filed 10 patents out of which 3 are granted

DR. SIVARAMA KRISHNAN

A seasoned and accomplished lawyer based in Mumbai with over three decades of legal practice. As a former Judge Advocate General (JAG) officer in the Indian Army and a panel counsel for the Securities and Exchange Board of India (2002-2005), a legal retainer to foreign funds invested in Indian capital markets, she brings a wealth of expertise across various domains of the legal industry. She successfully represented global clients in mergers and acquisitions involving Indian companies. Her core expertise and experience lie in the financial services and capital markets sectors, where she is proficient in advising international clients on investment laws in India, including compliance with FEMA, SEBI, company law, and regulations related to foreign direct investment (FDI) and foreign portfolio investment (FPI) and various other industries. She values diligence, knowledge, creativity, and innovation in addressing her client’s legal and regulatory needs by advising them well in advance on their industry's legal and compliance needs to save them from legal pitfalls in the future. She also believes that building supportive, long-term relationships with her clients enables her to anticipate all possible legal and regulatory implications of potential commercial opportunities, as well as the capability to efficiently resolve any legal obstacles and disputes affecting her clients.

CAPT. DEEPA KURUVILLA, ADVOCATE